Patient and Physician Perspectives on the Benefits and Risks of Antiplatelet Therapy for Acute Coronary Syndrome

M Cohen, C Jones - Cardiology and Therapy, 2024 - Springer
This article is co-authored by a patient with acute coronary syndrome (ACS) who is receiving
long-term antiplatelet therapy in the USA and a cardiologist who routinely treats patients with …

Ticagrelor monotherapy after acute coronary syndrome: lessons from the ULTIMATE-DAPT trial

F Gragnano, VD Sio, A Cesaro, P Calabrò - Future Cardiology, 2024 - Taylor & Francis
Dual antiplatelet therapy (DAPT) for 12 months is the current standard of care in patients
with acute coronary syndrome (ACS), regardless of stent implantation, and is endorsed by …